title: Hydrophobic end-gated silica nanotubes for intracellular glutathione-stimulated drug delivery in drug-resistant cancer cells.
abstract: Intracellular glutathione-triggered doxorubicin release from silica nanotubes with hydrophobic labile cap was demonstrated for the drug-resistant cancer cell treatment.
authors: Department of Chemistry, Gachon University, Seongnam, 461-701, Korea.
authors: Lulu
authors: L
authors: Wang
authors: Mira
authors: M
authors: Kim
authors: Qiling
authors: Q
authors: Fang
authors: Junhong
authors: J
authors: Min
authors: Won Il
authors: WI
authors: Jeon
authors: So Yeong
authors: SY
authors: Lee
authors: Sang Jun
authors: SJ
authors: Son
authors: Sang-Woo
authors: SW
authors: Joo
authors: Sang Bok
authors: SB
authors: Lee
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000633:toxicity; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000633:toxicity; D004337:Drug Carriers / Q000737:chemistry*; D019008:Drug Resistance, Neoplasm; D005978:Glutathione / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D061986:MCF-7 Cells; D051379:Mice; D008819:Mice, Nude; D043942:Nanotubes / Q000737:chemistry*; D009369:Neoplasms / Q000188:drug therapy; D012822:Silicon Dioxide / Q000737:chemistry*; D014183:Transplantation, Heterologous
chemical_list: D000903:Antibiotics, Antineoplastic; D004337:Drug Carriers; D012822:Silicon Dioxide; D004317:Doxorubicin; D005978:Glutathione